These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32045695)

  • 1. The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005-2018.
    Guo Y; Zhang L; Feng D; Zhao S; Liu Q; Xu J; Lu M; Li J; Zhang Y; Guo W
    Int J Infect Dis; 2020 Apr; 93():163-167. PubMed ID: 32045695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
    Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
    Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China].
    Kong Q; Yan BY; Lyu JJ; Feng Y; Liu JY; Song LZ; Xu Q; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):480-483. PubMed ID: 28592089
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China - A cross-sectional study.
    Xiaojin S; Rodewald LE; Guomin Z; Hui Z; Ning M; Fuzhen W; Zundong Y
    Vaccine; 2020 Dec; 38(52):8302-8309. PubMed ID: 33213930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Sun X; Wang F; Zheng H; Miao N; Yuan Q; Cui F; Yin Z; Zhang G; Levine H
    Vaccine; 2018 Feb; 36(10):1279-1284. PubMed ID: 29398275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017.
    Wang H; Gao P; Chen W; Bai S; Lv M; Ji W; Pang X; Wu J
    Hum Vaccin Immunother; 2019; 15(2):420-425. PubMed ID: 30260275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
    Zhang ZL; Zhu XJ; Shan AL; Gao ZG; Zhang Y; Ding YX; Liu H; Wu WS; Liu Y; He HY; Xie XH; Xia WD; Li C; Xu WT; Li ZY; Lin HL; Fu WM
    Hum Vaccin Immunother; 2014; 10(4):1008-12. PubMed ID: 24503599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated hepatitis A vaccines developed in China.
    Xu ZY; Wang XY
    Hum Vaccin Immunother; 2014; 10(3):659-66. PubMed ID: 24280971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System.
    Wang F; Sun X; Wang F; Zheng H; Jia Z; Zhang G; Bi S; Miao N; Zhang S; Cui F; Li L; Wang H; Liang X; Rodewald LE; Feng Z; Yin Z; Shen L
    Hepatology; 2021 Apr; 73(4):1251-1260. PubMed ID: 32592242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Souto FJD; de Brito WI; Fontes CJF
    Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.
    Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C
    BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].
    Li JP; Gao ZX; Zhou J
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):238-40. PubMed ID: 20726266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation].
    Zhuang F; Jiang Q; Gong Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):188-90. PubMed ID: 11860874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
    Barkai G; Belmaker I; Givon-Lavi N; Dagan R
    Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
    Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
    J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
    Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.